Azacitidine/Venetoclax Induced Remission of Intermediate-Risk Acute Myeloid Leukemia with the Rare t(7;10): a case report

Authors
Category Systematic review
Conference2024 Lymphoma Leukemia and Myeloma Congress
Year 2024
This article has no abstract
Epistemonikos ID: 41f2a83d69bb700513b4e1400636e557ae337846
First added on: Jan 06, 2026